Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

311 Views

I1. Adult Vaccines

Poster Session: Adult Vaccines

(P-24) Toward the clinical development of ATI-1701, a genetically defined live attenuated tularemia vaccine

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Gary S. Nabors, PhD (he/him/his)

Chief Development Officer
Appili Therapeutics
Laytonsville, Maryland, United States

Co-Author(s)

AB

Arthur Baran, MS

Director of Product Development
Appili Therapeutics
Frederick, Maryland, United States
CG

Carl Gelhaus, Ph.D.

Director of Nonclinical Research
Appili Therapeutics
Frederick, Maryland, United States